1-7 of 7
Daniel T. Johnson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemia

Amanda G. Davis, Daniel T. Johnson, Dinghai Zheng, Ruijia Wang, Nathan D. Jayne, Mengdan Liu, Jihae Shin, Luyang Wang, Samuel A. Stoner, Jie-Hua Zhou, Edward D. Ball, Bin Tian, Dong-Er Zhang
Journal: Blood
Blood (2022) 139 (3): 424–438.
https://doi.org/10.1182/blood.2020005693
Published: 2022
Journal Articles

Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation

Samuel A. Stoner, Ming Yan, Katherine Tin Heng Liu, Kei-Ichiro Arimoto, Takahiro Shima, Huan-You Wang, Daniel T. Johnson, Rafael Bejar, Catriona Jamieson, Kun-Liang Guan, Dong-Er Zhang
Journal: Blood
Blood (2019) 134 (20): 1730–1744.
https://doi.org/10.1182/blood.2019000170
Published: 2019
Includes: Supplemental data
Journal Articles

Development of Acute Myeloid Leukemia Cell Membrane Coated Nanoparticles (AMCNPs) for Cancer Vaccination Immunotherapy

Daniel T Johnson, Ashley V Kroll, BS, Ronnie H Fang, PhD, Justin Kline, MD, Liangfang Zhang, PhD, Dong-Er Zhang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4062.
https://doi.org/10.1182/blood-2018-99-117841
Published: 2018
Journal Articles

CPSF1-Mediated Acute Myeloid Leukemia Fusion 3'UTR Alternation Is a Potential Therapeutic Target

Takahiro Shima, MD PhD, Amanda G Davis, Daniel T Johnson, Yu Kochi, MD, Sayuri Miyauchi, DDS, PhD, Samuel A Stoner, Junichiro Yuda, MD, Toshihiro Miyamoto, MD PhD, Jie-Hua Zhou, MD, Edward D. Ball, MD, Koichi Akashi, MD PhD, Dong-Er Zhang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 885.
https://doi.org/10.1182/blood-2018-99-119199
Published: 2018
Journal Articles

A Phase I Study of FLX925, a Dual FLT3 and CDK4/6 Inhibitor in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

Naval Daver, MD, Daniel A. Pollyea, MD, David A. Rizzieri, MD, Jeanne Palmer, MD, Raajit K. Rampal, MD PhD, Shira Dinner, MD, Dale L. Bixby, MD PhD, Mary-Elizabeth M. Percival, MD, Tibor Kovacsovics, Kebede H. Begna, MD, Alexander E. Perl, MD, Marina Konopleva, MD PhD, Lisa Seitz, MS, Jenny McKinnell, Daniel T Johnson, BS, William Ho, MD PhD, Jorge E. Cortes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1343.
https://doi.org/10.1182/blood.V130.Suppl_1.1343.1343
Published: 2017
Journal Articles

Characterization of the Post-Transcriptional Regulation of AML1-ETO Expression in t(8;21) Leukemia Cells

Daniel T Johnson, BS, Takahiro Shima, MD PhD, Amanda G Davis, BS, Dong-Er Zhang, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3790.
https://doi.org/10.1182/blood.V130.Suppl_1.3790.3790
Published: 2017
Journal Articles

CPSF1 Regulates AML1-ETO Fusion Gene Polyadenylation and Stability in t(8;21) Acute Myelogenous Leukemia

Takahiro Shima, MD PhD, Amanda G Davis, Sayuri Miyauchi, DDS, PhD, Yu Kochi, MD, Daniel T Johnson, Samuel A Stoner, BS, Yuda Junichiro, MD, Toshihiro Miyamoto, MD PhD, Jie-Hua Zhou, MD, Edward D Ball, MD, Koichi Akashi, MD PhD, Dong-Er Zhang, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2498.
https://doi.org/10.1182/blood.V130.Suppl_1.2498.2498
Published: 2017